Supplementary Figure 1 from A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies

Autor:	Bayard L. Powell, Susan Lyerly, Sarah Dralle, Megan Manuel, Robin Harrelson, Leslie R. Ellis, David Hurd, Denise Levitan, Kristin M. Stadelman, Lance D. Miller, Scott Isom, Robert Rodriguez, Claudia Maturo, John Luddy, King Lee, Timothy S. Pardee
Rok vydání:	2023
DOI:	10.1158/1078-0432.22457619
Popis:	Supplementary Figure 1. Pharmacokinetics of CPI-613 infused over 1 hour. Plasma CPI-613 levels following a 1 or 2 hour infusion shown on day 1 and day 6 on a linear scale. The number of patients in each analysis is indicated by n. **=p
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3fb3529a0980ffa12d525b98fdf809 https://doi.org/10.1158/1078-0432.22457619 Zobrazit plný text záznamu